Produk Naam: Dehydronandrolone Acetate
Sinonieme: Dehydronandrolone Acetate;Dehydronandrolone-6 Acetate
CAS: 2590-41-2
MF: C20H26O3
MW: 314.42
LP: 95-98°C
Berging temp: Controlled Substance, -20°C Freezer
Voorkoms: wit poeier
Dehydronandrolone acetate is a key intermediate for the synthesis of fulvestrant (faslodex) and tibolone, while the former was an anti-breast-cancer drug developed by AstraZeneca Company and the latter was a synthetic steroid marketed by Organon Company for post climacteric complains. It is an effective compound that produces quality, long-lasting muscle gains. This is because of the relatively long half-life of the drug. Users report mild side effects, with the biggest side effect being water retention.
Dehydronandrolon acetate(CAS: 2590-41-2) is an effective compound that produces quality, long-lasting muscle gains. This is because of the relatively long half-life of the drug. Users report mild side effects, with the biggest side effect being water retention.
Dehydronandrolon acetate is an effective compound that produces quality, long-lasting muscle gains,with the biggest side effect being water retention.
| Items van ontleding |
Spesifikasie |
Resultate |
| Beskrywing |
White to light yellow crystalline powder |
Wit kristallyne poeier |
| Smeltpunt |
≥100℃ |
107℃ |
| Spesifieke optiese rotasie |
-20°～-26° |
-22.5° |
| Verlies op droog |
≤0,5% |
0.15% |
| Identifikasie |
Test preparation has maximum
absorption at 282±2nm by
ultraviolet – visible spectrophotometry. |
Gekwalifiseerd |
| Maximum single impurity |
≤1,0% |
0.3% |
| Totale onsuiwerhede |
≤5.0% |
0.8% |
| Assay |
≥95.0% |
99.45% |
| Gevolgtrekking |
Gekwalifiseerd |
